Question

help please

Which is the MOA for montelukast? It excites leukotriene receptors which improves bronchoconstriction. It inhibits leukotriene receptors which can help prevent bronchoconstriction and asthma attacks. It excites leukotriene receptors which causes bronchodilation. It inhibits leukotriene receptors which exacerbates bronchoconstriction and asthma attacks.

Answer 1

Answer: It inhibits leukotriene receptors which can prevent bronchoconstriction and asthama attack.

( The montelukast inhibits the action of leukotriene D4 in the lungs, this reduces the inflammation as well as smoothens the muscles.)